Skip to main content
Equibles
LTC logo

LTC · Ltc Properties Inc

Track LTC — free

Use LTC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$41.21 -0.69 (-1.65%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.22B
Shares
53.91M

LTC metrics

84 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$41.21
Market cap
$2.22B

Price action

19 metrics
Price change (1W)
+1.5%
Price change (30D)
+3.4%
Price change (3M)
+14.3%
Price change (6M)
+7.3%
Price change (YTD)
+19.9%
Price change (1Y)
+13.2%
Trailing year
Price change (5Y)
+19.2%
52-week high
$42.81
52-week low
$33.98
Change from 52-week high
-3.7%
Change from 52-week low
+21.3%
Annualized volatility
20.3%
Beta
-0.2
RSI (14D)
56.3
Price vs SMA 50
+2.5%
Price vs SMA 200
+8.5%
Avg volume (3M)
567,713
Relative volume
0.8
Average dollar volume
$22.33M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
53.91M

Valuation

12 metrics
P / E (TTM)
14.8
Trailing earnings · reciprocal yield 6.8%
PEG ratio
0.2
EV / revenue
8.5×
reciprocal yield 11.8%
EV / EBITDA
11.3×
reciprocal yield 8.9%
EV / EBIT
13.6×
reciprocal yield 7.4%
P / sales
6.4×
reciprocal yield 15.7%
P / book
1.8
reciprocal yield 57.1%
FCF yield
—
TTM · current market cap
Buyback yield
0.8%
P / FCF
—
P / operating cash flow
15.7
reciprocal yield 6.4%
Earnings yield
6.0%

Historical valuation

8 metrics
P / E historical average (3Y)
19.0×
reciprocal yield 5.3%
P / E historical average (5Y)
19.0×
reciprocal yield 5.3%
EV / revenue historical average (3Y)
10.8×
reciprocal yield 9.3%
EV / revenue historical average (5Y)
11.8×
reciprocal yield 8.5%
EV / EBIT historical average (3Y)
22.0×
reciprocal yield 4.6%
EV / EBIT historical average (5Y)
25.0×
reciprocal yield 4.0%
EV / EBITDA historical average (3Y)
16.1×
reciprocal yield 6.2%
EV / EBITDA historical average (5Y)
17.4×
reciprocal yield 5.7%

Dividends & buybacks

7 metrics
Dividend yield
5.5%
Trailing 12 months
Payout ratio
84.2%
Shareholder yield
—
Dividend / share (TTM)
$2.28
Dividend growth YoY
+0.0%
Dividend growth streak
—
Last ex-dividend
2026-08-21

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
62.6%
Trailing 12 months
Net margin
38.5%
Gross profit (TTM)
—
Operating profit (TTM)
$217.75M
Net income (TTM)
$133.89M
Trailing 12 months
Diluted EPS (TTM)
$2.79
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$17.29

Growth

11 metrics
Revenue growth YoY
+64.1%
Year over year
Net income growth YoY
+96.4%
Revenue (TTM)
$347.85M
Trailing 12 months
EPS growth YoY
+75.0%
Shares change YoY
+13.4%
Year over year · more shares
Revenue CAGR (3Y)
+14.5%
Revenue CAGR (5Y)
+10.5%
EPS CAGR (3Y)
+0.5%
EPS CAGR (5Y)
+0.8%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
10.6%
Return on assets
6.2%
Debt / equity
0.6
Current ratio
—
EBITDA (TTM)
$262.03M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
5.5
Net debt / EBITDA
2.8
Return on invested capital
—
Trailing 12 months
Net cash
−$736.65M
Latest balance sheet
Cash & equivalents
$40.44M
Total assets
$2.18B
Total debt
$777.09M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$141.52M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$8.67M
R&D / revenue
—
Stock compensation / revenue
2.5%

Ownership (13F)

3 metrics
13F filers
291
13F filer change QoQ
+2
Institutional ownership
80.0%

Short interest

3 metrics
Short interest
4.3%
Latest settlement · 4.3 days to cover
Days to cover
4.3d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
$29,638
Insider-sentiment score
71 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 887905 CUSIP 502175102 13F (30d) 189 filings 188 filers Visit website Investor relations